Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09CQO
|
||||
Former ID |
DNC012024
|
||||
Drug Name |
2-Thiophen-2-yl-3H-imidazo[4,5-c]quinoline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [534155] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H9N3S
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C3=C(C=N2)NC(=N3)C4=CC=CS4
|
||||
InChI |
1S/C14H9N3S/c1-2-5-10-9(4-1)13-11(8-15-10)16-14(17-13)12-6-3-7-18-12/h1-8H,(H,16,17)
|
||||
InChIKey |
APVZAVOHLAQECW-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Gamma-aminobutyric acid receptor subunit alpha-1 | Target Info | Inhibitor | [534155] | |
Gamma-aminobutyric acid receptor subunit gamma-2 | Target Info | Inhibitor | [534155] | ||
Gamma-aminobutyric acid receptor | Target Info | Inhibitor | [534155] | ||
Gamma-aminobutyric acid receptor subunit beta-2 | Target Info | Inhibitor | [534155] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.